Evidence map›Paper›PMID 22814600›Full record

ArticleDevelopmental cell2012

Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT.

William R Goodyer, Xueying Gu, Yinghua Liu, Rita Bottino, Gerald R Crabtree, Seung K Kim

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 112 citations in OpenAlex.

  1. Postnatal refinement of CaChannels (Austin, Tex.) · 2026
    Article
  2. Article
  3. Article
  4. Tacrolimus and diabetic rodent models.Pharmacological reports : PR · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CaBiomedicines · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Ser/Thr phosphatases: One of the key regulators of insulin signaling.Reviews in endocrine & metabolic disorders · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Dynamic changes in β-cell [CaMolecular metabolism · 2022
    Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

William R GoodyerDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Xueying Gu
Yinghua Liu
Rita Bottino
Gerald R Crabtree
Seung K Kim
Stanford University · USHoward Hughes Medical Institute · USUniversity of Pittsburgh · US

Funding

Regulation of Facultative Islet Growth and Development by Calcineurin and NFATR01DK075919 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2006 to 2010
$1.6M
NFAT Signaling and Down SyndromeR01HD055391 · NICHD · STANFORD UNIVERSITY · PI CRABTREE, GERALD R. · 2008 to 2012
$1.4M
Howard Hughes Medical InstituteNICHD NIH HHS R01 HD055391NICHD NIH HHS R01HD55391NIDDK NIH HHS R01 DK075919
6 · The paper itself

Abstract

Little is known about the mechanisms governing neonatal growth and maturation of organs. Here we demonstrate that calcineurin/Nuclear Factor of Activated T cells (Cn/NFAT) signaling regulates neonatal pancreatic development in mouse and human islets. Inactivation of calcineurin b1 (Cnb1) in mouse islets impaired dense core granule biogenesis, decreased insulin secretion, and reduced cell proliferation and mass, culminating in lethal diabetes. Pancreatic β cells lacking Cnb1 failed to express genes revealed to be direct NFAT targets required for replication, insulin storage, and secretion. In contrast, glucokinase activation stimulated Cn-dependent expression of these genes. Calcineurin inhibitors, such as tacrolimus, used for human immunosuppression, induce diabetes. Tacrolimus exposure reduced Cn/NFAT-dependent expression of factors essential for insulin dense core granule formation and secretion and neonatal β cell proliferation, consistent with our genetic studies. Discovery of conserved pathways regulating β cell maturation and proliferation suggests new strategies for controlling β cell growth or replacement in human islet diseases.

Indexed as

AdultAnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsCalcineurinCell DifferentiationCell Line, TumorChild, PreschoolHumansInfantInfant, NewbornInsulin-Secreting CellsMiceMice, Inbred C57BLMice, KnockoutMiddle AgedBasic Helix-Loop-Helix ProteinsCalcineurinNerve Tissue ProteinsNeurog3 protein, mouseNFATC1 protein, humanNFATC Transcription FactorsPPP3R1 protein, human

Identifiers

PMID22814600
PMCPMC3587727
OpenAlexW2075232662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.